Pulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomized clinical trial results and explored novel strategies to enhance patient outcomes. Their findings uncovered key data essential for improving clinical care.

In this interview, Drs. William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease.

Subscribe on Apple Podcasts | Subscribe to ACCEL